ES2066902T3 - Soluciones estables de analogos de rebecamicina y su preparacion. - Google Patents

Soluciones estables de analogos de rebecamicina y su preparacion.

Info

Publication number
ES2066902T3
ES2066902T3 ES90108739T ES90108739T ES2066902T3 ES 2066902 T3 ES2066902 T3 ES 2066902T3 ES 90108739 T ES90108739 T ES 90108739T ES 90108739 T ES90108739 T ES 90108739T ES 2066902 T3 ES2066902 T3 ES 2066902T3
Authority
ES
Spain
Prior art keywords
stable
rebeccamycin
acid
rebecamicine
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90108739T
Other languages
English (en)
Inventor
Ubrani V Venkataram
Miriam K Franchini
Joseph B Bogardus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2066902T3 publication Critical patent/ES2066902T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

DICHAS SOLUCIONES ESTABLES SON ESENCIALMENTE DE A) AGUA, B) 8 - N (DIETILAMINOETIL) - REBECAMICINA, EN UNA DOSIS EFECTIVA Y C) UN ACIDO FARMACEUTICAMENTE ACEPTABLE QUE EN PRESENCIA DE UN EQUIVALENTE MOLAR DEL MISMO SOLUBILIZA B), CIHO ACIDO TIENE UN EXCESO DE DICHO EQUIVALENTE MOLAR PARA ESTABILIZAR EL PH DE 3 A 4, PREFERIBLEMENTE DE 3.0 A 3.6. OTRA SOLUCION CONTIENE 10 MG/ML DE UNA BASE LIBRE Y DE ACIDO TARTARICO EN CANTIDAD EQUIMOLAR CON LA BASE LIBRE PARA OFRECER UN PH DE 3.5. LA SOLUCION SE PREPARA PREFERIBLEMENTE POR LA FORMACION DE UNA SUSPENSION DE B) EN AGUA Y A/ADIENDO UN ACIDO PARA CONSEGUIR EL PH DE 3 A 4.
ES90108739T 1989-05-10 1990-05-09 Soluciones estables de analogos de rebecamicina y su preparacion. Expired - Lifetime ES2066902T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/349,608 US5496809A (en) 1989-05-10 1989-05-10 Stable solutions of rebeccamycin analog

Publications (1)

Publication Number Publication Date
ES2066902T3 true ES2066902T3 (es) 1995-03-16

Family

ID=23373191

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90108739T Expired - Lifetime ES2066902T3 (es) 1989-05-10 1990-05-09 Soluciones estables de analogos de rebecamicina y su preparacion.

Country Status (24)

Country Link
US (1) US5496809A (es)
EP (1) EP0397147B1 (es)
JP (1) JPH0643437B2 (es)
KR (1) KR920004098B1 (es)
CN (1) CN1054510C (es)
AT (1) ATE117313T1 (es)
AU (1) AU618896B2 (es)
CA (1) CA2015632C (es)
CZ (1) CZ283416B6 (es)
DE (1) DE69016087T2 (es)
DK (1) DK0397147T3 (es)
EG (1) EG19218A (es)
ES (1) ES2066902T3 (es)
FI (1) FI95777C (es)
GR (1) GR3015714T3 (es)
HU (1) HU206627B (es)
IE (1) IE66515B1 (es)
IL (1) IL94312A (es)
NO (1) NO176390C (es)
PT (1) PT93991B (es)
RU (1) RU2053766C1 (es)
TW (1) TW202390B (es)
YU (1) YU90490A (es)
ZA (1) ZA903535B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547976A (en) * 1992-03-20 1996-08-20 Burroughs Wellcome Co. Further indole derivatives with antiviral activity
US5968961A (en) * 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
WO1998019707A1 (en) * 1996-11-05 1998-05-14 Alcon Laboratories, Inc. Polyhydroxy monocarboxylic and dicarboxylic acids and their lactones in ophthalmic compositions
US20040048012A1 (en) * 1996-11-18 2004-03-11 Weder Donald E. Polymeric materials having a matte finish on a surface thereof
CA2241609C (en) * 1997-06-26 2009-08-25 Southpac Trust International, Inc. Polymeric material having a cloth-like appearance
RU2185819C1 (ru) * 2001-10-18 2002-07-27 Дорофеенко Алла Ивановна Средство, обладающее противоопухолевым действием
RU2203056C1 (ru) * 2002-06-18 2003-04-27 Нестерук Владимир Викторович Способ получения твердой лекарственной формы препарата на основе дибазола
CN100344285C (zh) * 2005-02-03 2007-10-24 宋艳 多潘立酮水溶性制剂及其制备方法
JP4822151B2 (ja) * 2005-02-14 2011-11-24 山本光学株式会社 眼鏡保持バンドおよびその保持バンド付き眼鏡

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
US4808613A (en) * 1986-11-21 1989-02-28 Bristol-Myers Company Rebeccamycin derivative containing pharmaceutical composition

Also Published As

Publication number Publication date
CA2015632C (en) 1998-01-27
YU90490A (en) 1991-10-31
HK1005033A1 (en) 1998-12-18
EP0397147A3 (en) 1991-06-12
CN1047204A (zh) 1990-11-28
DK0397147T3 (da) 1995-03-20
CN1054510C (zh) 2000-07-19
EP0397147A2 (en) 1990-11-14
FI95777C (fi) 1996-03-25
EP0397147B1 (en) 1995-01-18
NO176390C (no) 1995-03-29
NO176390B (no) 1994-12-19
ZA903535B (en) 1991-01-30
FI95777B (fi) 1995-12-15
IL94312A (en) 1994-02-27
FI902276A0 (fi) 1990-05-07
IE66515B1 (en) 1996-01-10
PT93991B (pt) 1996-11-29
NO902048D0 (no) 1990-05-09
ATE117313T1 (de) 1995-02-15
KR920004098B1 (ko) 1992-05-25
AU5482390A (en) 1990-11-15
CZ283416B6 (cs) 1998-04-15
CA2015632A1 (en) 1990-11-10
TW202390B (es) 1993-03-21
HUT54053A (en) 1991-01-28
JPH0317094A (ja) 1991-01-25
PT93991A (pt) 1991-02-08
IE901687L (en) 1990-11-10
JPH0643437B2 (ja) 1994-06-08
HU206627B (en) 1992-12-28
NO902048L (no) 1990-11-12
HU902989D0 (en) 1990-09-28
IL94312A0 (en) 1991-03-10
KR900017596A (ko) 1990-12-19
CZ225590A3 (en) 1997-12-17
US5496809A (en) 1996-03-05
DE69016087T2 (de) 1995-05-24
EG19218A (en) 1994-10-30
AU618896B2 (en) 1992-01-09
RU2053766C1 (ru) 1996-02-10
DE69016087D1 (de) 1995-03-02
GR3015714T3 (en) 1995-07-31

Similar Documents

Publication Publication Date Title
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
UA19303A (uk) Спосіб одержаhhя похідhих 2-аhіліhопіримідиhу
SE8603582L (sv) Komposition innehallande l-dopa
DK232989D0 (da) Antiviralt praeparat
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
FI843286A0 (fi) Stabil, sur vattenloesning av cis-platina laemplig foer injektion.
ES2066902T3 (es) Soluciones estables de analogos de rebecamicina y su preparacion.
DE3863859D1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
FR2681863B1 (fr) Solution de sparfloxacine sa preparation et sel la constituant.
DK197089D0 (da) Laegemidler indeholdende pentamidin
DK443988A (da) Injektionspraeparat indeholdende modificeret tpa
NO972303L (no) Intravenöse lubeluzollösninger
MY104606A (en) Aqueous high concentration composition of alpha-sulfofa -tty acid ester salt.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 397147

Country of ref document: ES